Cargando…

Good outcomes of pregnancy in two cases of women treated with omalizumab due to the severe asthma

Detalles Bibliográficos
Autores principales:	Kuprys-Lipinska, Izabela, Kuna, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647300/ http://dx.doi.org/10.1186/2045-7022-3-S1-P25

Ejemplares similares

Omalizumab in pregnant women treated due to severe asthma: two case reports of good outcomes of pregnancies
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2014)

Loss of asthma control after cessation of omalizumab treatment: real life data
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2014)

Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2016)

Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2018)

Effectiveness and adverse events of plasmapheresis and immunoglobulin G infusion in patient with resistant chronic urticaria and angioedema - a case report
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2015)

Effectiveness of omalizumab in an asthmatic patient with severe airway and blood eosinophilia
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2015)

Effectiveness of omalizumab in a patient with a life-threatening episode of bronchospasm and larynx angioedema after exposure to house dust
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2014)

New approach to intermittent and mild asthma therapy: evolution or revolution in the GINA guidelines?
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2020)

Omalizumab for severe allergic asthma: a life changing drug?
por: Mesonjesi, Eris, et al.
Publicado: (2015)

Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients
por: Mauri, Pierluigi, et al.
Publicado: (2014)

P23 - Boy with severe atopic dermatitis treated with omalizumab
por: Stefanaki, Evangelia, et al.
Publicado: (2014)

Polish Society of Allergology statement on the diagnosis and treatment of severe, difficult-to-control bronchial asthma
por: Kupczyk, Maciej, et al.
Publicado: (2019)

The dynamics of the manifestations of atopic dermatitis in severe persistent uncontrolled asthma children with omalizumab therapy
por: Vishneva, Elena, et al.
Publicado: (2015)

Omalizumab: clinical use for the treatment of an adolescent with difficult asthma
por: De Castro, Giovanna, et al.
Publicado: (2013)

Prevalence, risk factors and underdiagnosis of asthma in the general population aged over 60 years
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2019)

Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma
por: Lambert, Nathalie, et al.
Publicado: (2015)

The position paper of the Polish Society of Allergology on climate changes, natural disasters and allergy and asthma
por: Pałczyński, Cezary, et al.
Publicado: (2018)

Omalizumab as successful treatment option in severe peanut allergy
por: Dehlink, E, et al.
Publicado: (2013)

287 Nasal Nitric Oxide Levels after Lysine Aspirin Nasal Challenge in Subjects with Aspirin Induced Asthma
por: Tworek, Damian, et al.
Publicado: (2012)

Poster 1012: Safety and efficacy of omalizumab in 10 children with asthma and other allergic comorbidities
por: Aguiar, Rita, et al.
Publicado: (2014)

Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2013)

Severe food allergy in children. Omalizumab as an alternative treatment to elimination diet
por: Pena Peloche, María, et al.
Publicado: (2011)

Metabolomic applied to omalizumab effect in severe asthmatics – a preliminary result
por: Loureiro, Cláudia Chaves, et al.
Publicado: (2013)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Influence of the diagnosis chronic rhinosinusitis on asthma response to omalizumab in severe, uncontrolled asthmatics
por: Sintobin, Ina, et al.
Publicado: (2015)

PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab
por: Vilella, Mireia, et al.
Publicado: (2014)

COVID‐19 in a patient with severe asthma treated with Omalizumab
por: Lommatzsch, Marek, et al.
Publicado: (2020)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
por: Humbert, Marc, et al.
Publicado: (2013)

Expression of cPLA(2)γ mRNA and protein differs the response of PBMC from severe and non-severe asthmatics to bacterial lipopolysaccharide and house dust mite allergen
por: Pniewska-Dawidczyk, Ewa, et al.
Publicado: (2021)

The Step Further to Understand the Role of Cytosolic Phospholipase A(2) Alpha and Group X Secretory Phospholipase A(2) in Allergic Inflammation: Pilot Study
por: Pniewska, Ewa, et al.
Publicado: (2014)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

279 Near-Fatal Asthma Treated with Omalizumab
por: Contreras Contreras, Elvia Angelica, et al.
Publicado: (2012)

Omalizumab for the treatment of severe allergic asthma in children: A tale of two
por: Brannick, Sinéad, et al.
Publicado: (2022)

A review of omalizumab for the management of severe asthma
por: Lin, Ching-Hsiung, et al.
Publicado: (2016)

Poster 1014: Omalizumab efficiency in patients with allergic rhinitis and chronic sinusitis
por: Gonzalez-Diaz, Sandra Nora, et al.
Publicado: (2014)

BiPAP for treating moderate and severe asthma exacerbations in a PED
por: Williams, A, et al.
Publicado: (2013)

Expression of Transcript Variants of PTGS1 and PTGS2 Genes among Patients with Chronic Rhinosinusitis with Nasal Polyps
por: Pietruszewska, Wioletta, et al.
Publicado: (2021)

P87 - A national multicenter registration of treatment with omalizumab in Danish asthmatic children
por: Spangenberg, Katrine B, et al.
Publicado: (2014)

Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab
por: De Schryver, Els, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jvqu2abhje6k7ktkjl1oud6vdk